Newsletter | November 20, 2026

11.20.26 -- Oversight Monitoring In Clinical Trials

CLINICAL DATA MANAGEMENT & ANALYTICS

Where Are We With Tokenization?

In January 2024, I asked Tom Dougherty about a topic many clinical research professionals had heard mentioned, but few could confidently explain: tokenization. To catch up on progress since then, I completed this Q&A with Dougherty, who is a Real-World Data Strategy Director, CMR - Clinical Data Science & Evidence at Novo Nordisk.

CSA Gap Assessment

Learn how life sciences organizations are shifting from CSV to CSA using risk-based validation, automated testing, supplier leverage, and AI-ready compliance strategies.

Hidden Costs Of Data Cleaning: Build Quality At The Source

Hidden costs from downstream data cleaning slow trials and raise risk. Explore why building quality at the source accelerates timelines, reduces errors, and gives sponsors a competitive edge.

How Clinical Trials Are Moving From Digitized To Agentified

See how generative and agentic AI can streamline clinical trials, with independent analysis modeling up to $21M in value and 82x ROI for agent-enabled monitoring.

Adherence Monitoring Solutions: Choose The Right Level Of Support

Help your study team curb trial costs and delays by monitoring adherence in near real time. These tools automate reporting and issue alerts to maximize data capture and regulatory readiness.

Analyze Audit Trail Data With Generative AI

Stop reviewing audit trails line by line. Learn how AI helps study teams pinpoint high-risk sites, spot unusual data patterns, and pull targeted audit data in minutes, not days.

AI-Powered Workflows: Accelerating Trial Execution

AI in clinical development allows our teams to surface predictive insights at every stage, reducing protocol risk, study delays, and costly trial amendments.

TRIAL MONITORING

Monitors Under ICH E6(R3)

Discover how medical monitor-led implementation of ICH E6(R3) outperforms operations-only models across six critical performance dimensions.

Oversight Monitoring In Clinical Trials

By engaging early and aligning oversight practices with inspection readiness goals, organizations can protect trial integrity, shorten development timelines, and reinforce patient safety.

Central Laboratory Solutions

Global clinical trials need central laboratory networks able to scale across countries while keeping biomarker and biospecimen data consistent from one study site to the next.

PPD Monitoring Application (MApp): A Flexible Technical Solution

This dynamic, system-agnostic approach to modernizing clinical trial monitoring supports targeted oversight, as well as sampling at the subject, visit, and form levels.

Connect With Clinical Leader: